Report of the national heart, lung, and blood institute working group on the translation of cardiovascular molecular imaging

Circulation

Volumn 123, Issue 19, 2011, Pages 2157-2163

  Buxton, Denis B ^a   Antman, Melissa ^a   Danthi, Narasimhan ^a   Dilsizian, Vasken ^b   Fayad, Zahi A ^c   Garcia, Mario J ^d   Jaff, Michael R ^e   Klimas, Michael ^f   Libby, Peter ^g   Nahrendorf, Matthias ^e   Sinusas, Albert J ^h   Wickline, Samuel A ⁱ   Wu, Joseph C ^j   Bonow, Robert O ^k   Weissleder, Ralph ^e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h YALE UNIVERSITY   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j STANFORD UNIVERSITY   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

cardiovascular diseases; diagnosis; molecular imaging

Indexed keywords

IODINE 123;

AORTA ANEURYSM; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; FLUORESCENCE; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; ULTRASOUND; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; UNITED STATES;

EID: 79957477246     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.000943     Document Type: Article

References (44)

1. Jaffer FA Libby P Weissleder R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017-1024.
2. Jaffer FA Vinegoni C John MC Aikawa E Gold HK Finn AV Ntziachristos V Libby P Weissleder R. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118:1802-1809.
3. Upadhyay R Sheth RA Weissleder R Mahmood U. Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology. 2007;245:523-531.
4. Nahrendorf M Sosnovik De French BA Swirski FK Bengel F Sadeghi MM Lindner JR Wu JC Kraitchman DL Fayad ZA Sinusas AJ. Multimodality cardiovascular molecular imaging part II. Circ Cardiovasc Imaging. 2009;2:56-70.
5. Zacharakis G Kambara H Shih H Ripoll J Grimm J Saeki Y Weissleder R Ntziachristos V. Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci USA. 2005;102:18 252-18 257.
6. Dobrucki LW Sinusas AJ. PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol. 2010;7:38-47.
7. Von Schulthess GK Schlemmer HP. A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S3-S9.
8. Jacobson AF Senior R Cerqueira MD Wong ND Thomas GS Lopez VA Agostini D Weiland F Chandna H Narula J. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55: 2212-2221.
9. Kramer CM Sinusas AJ Sosnovik De French BA Bengel FM. Multimodality imaging of myocardial injury and remodeling. J Nucl Med. 2010;51:107S-121S.
10. Rudd JH Hyafil F Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009-1016.
11. Cormode DP Skajaa T Fayad ZA Mulder WJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol. 2009;29:992-1000.
12. Mulder WJ Strijkers GJ van Tilborg GA Cormode DP Fayad ZA Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res. 2009;42: 904-914.
13. Sosnovik De Nahrendorf M Weissleder R. Magnetic nanoparticles for MR imaging: agents techniques and cardiovascular applications. Basic Res Cardiol. 2008;103:122-130.
14. Kaneda M Caruthers S Lanza G Wickline S. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng. 2009;37:1922-1933.
15. Tang TY Howarth SP Miller SR Graves MJ Patterson AJ JM UK-I Li ZY Walsh SR Brown AP Kirkpatrick PJ Warburton EA Hayes PD Varty K Boyle JR Gaunt ME Zalewski A Gillard JH. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol. 2009;53:2039-2050.
16. Plump AS Lum PY. Genomics and cardiovascular drug development. J Am Coll Cardiol. 2009;53:1089-1100.
17. Hyafil F Cornily JC Rudd JH Machac J Feldman LJ Fayad ZA. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med. 2009;50:959-965.
18. Cormode DP Skajaa T van Schooneveld MM Koole R Jarzyna P Lobatto ME Calcagno C Barazza A Gordon RE Zanzonico P Fisher EA Fayad ZA Mulder WJ. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett. 2008;8:3715-3723.
19. Schlomka JP Roessl E Dorscheid R Dill S Martens G Istel T Baumer C Herrmann C Steadman R Zeitler G Livne A Proksa R. Experimental feasibility of multi-energy photon-counting K-edge imaging in preclinical computed tomography. Phys Med Biol. 2008;53:4031-4047.
20. Morawski AM Lanza GA Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol. 2005; 16:89-92.
21. Hughes MS McCarthy JE Marsh JN Arbeit JM Neumann RG Fuhrhop RW Wallace KD Znidersic DR Maurizi BN Baldwin SL Lanza GM Wickline SA. Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. J Acoust Soc Am. 2007;121: 3542-3557.
22. Li C Wang LV. Photoacoustic tomography and sensing in biomedicine. Phys Med and Biol. 2009;54:R59-R97.
23. Libby P DiCarli M Weissleder R. The vascular biology of atherosclerosis and imaging targets. J Nucl Med. 2010;51:33S-37S.
24. El Aidi H Mani V Weinshelbaum KB Aguiar SH Taniguchi H Postley JE Samber DD Cohen EI Stern J van Der Geest RJ Reiber JH Woodward M Fuster V Gidding SS Fayad ZA. Cross-sectional prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med. 2009; 6:219-228.
25. Graebe M Pedersen SF Borgwardt L Hojgaard L Sillesen H Kjaer A. Molecular pathology in vulnerable carotid plaques: Correlation with [18]- fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg. 2009;37:714-721.
26. Dobrucki LW Dione DP Kalinowski L Dione D Mendizabal M Yu J Papademetris X Sessa WC Sinusas AJ. Serial noninvasive targeted imaging of peripheral angiogenesis: validation and application of a semiautomated quantitative approach. J Nucl Med. 2009;50:1356-1363.
27. Nchimi A Defawe O Brisbois D Broussaud TK Defraigne JO Magotteaux P Massart B Serfaty JM Houard X Michel JB Sakalihasan N. MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans. Radiology. 2010;254:973-981.
28. Pietila M Malminiemi K Ukkonen H Saraste M Nagren K Lehikoinen P Voipio-Pulkki LM. Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med. 2001;28:373-376.
29. Van Den Borne SWM Isobe S Verjans JW Petrov A Lovhaug D Li P Zandbergen HR Ni Y Frederik P Zhou J Arbo B Rogstad A Cuthbertson A Chettibi S Reutelingsperger C Blankesteijn WM Smits JFM Daemen MJAP Zannad F Vannan MA Narula N Pitt B Hofstra L Narula J. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol. 2008;52: 2017-2028.
30. Van Den Borne SWM Isobe S Zandbergen HR Li P Petrov A Wong ND Fujimoto S Fujimoto A Lovhaug D Smits JFM Daemen MJAP Blankesteijn WM Reutelingsperger C Zannad F Narula N Vannan MA Pitt B Hofstra L Narula J. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging. 2009;2:187-198.
31. Chen J Tung CH Allport JR Chen S Weissleder R Huang PL. Nearinfrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation. 2005;111:1800-1805.
32. Su H Spinale FG Dobrucki LW Song J Hua J Sweterlitsch S Dione DP Cavaliere P Chow C Bourke BN Hu XY Azure M Yalamanchili P Liu R Cheesman EH Robinson S Edwards DS Sinusas AJ. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112: 3157-3167.
33. Muzard J Sarda-Mantel L Loyau S Meulemans A Louedec L Bantsimba-Malanda C Hervatin F Marchal-Somme J Michel JB Le Guludec D Billiald P Jandrot-Perrus M. Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS One. 2009;4:e5585. http:// www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal. pone.0005585. Accessed April 14 2011.
34. Hofstra L Liem IH Dumont EA Boersma HH van Heerde WL Doevendans PA DeMuinck E Wellens HJJ Kemerink GJ Reutelingsperger CPM Heidendal GA. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209-212.
35. Sosnovik De Schellenberger EA Nahrendorf M Novikov MS Matsui T Dai G Reynolds F Grazette L Rosenzweig A Weissleder R Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med. 2005;54:718-724.
36. Sosnovik De Nahrendorf M Panizzi P Matsui T Aikawa E Dai G Li L Reynolds F Dorn GW II Weissleder R Josephson L Rosenzweig A. Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging. 2009;2:468-475.
37. Kanno S Wu Y-JL Lee PC Dodd SJ Williams M Griffith BP Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation. 2001;104:934-938.
38. Nahrendorf M Zhang H Hembrador S Panizzi P Sosnovik De Aikawa E Libby P Swirski FK Weissleder R. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008;117: 379-387.
39. Christen T Nahrendorf M Wildgruber M Swirski FK Aikawa E Waterman P Shimizu K Weissleder R Libby P. Molecular imaging of innate immune cell function in transplant rejection. Circulation. 2009; 119:1925-1932.
40. Swirski FK Wildgruber M Ueno T Figueiredo J-L Panizzi P Iwamoto Y Zhang E Stone JR Rodriguez E Chen JW Pittet MJ Weissleder R Nahrendorf M. Myeloperoxidase-rich Ly-6c- myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest. 2010;120:2627-2634.
41. Chan KL Teo K Dumesnil JG Ni A Tam J for the ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121:306-314.
42. Aikawa E Nahrendorf M Sosnovik D Lok VM Jaffer FA Aikawa M Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007; 115:377-386.
43. Mummery CL Davis RP Krieger JE. Challenges in using stem cells for cardiac repair. Sci Transl Med. 2010;2:27-17.
44. Lawall H Bramlage P Amann B. Stem cell and progenitor cell therapy in peripheral artery disease: a critical appraisal. Thromb Haemost. 2010;103:696-709.